Skip to content
1887

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has manifested as a multifaceted paradigm but has primarily affected the respiratory system. Though a rare sequela after-COVID-19, we present a case of cavitary lung lesion in an adult patient, which manifested with common symptoms such as fever, cough and dyspnoea during the post-COVID-19 recovery period. and were found to be the main causative organisms. Fungal and bacterial coinfection may be thought of in similar situations and appropriate treatment may be given to prevent further morbidity and mortality.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000457
2023-06-22
2025-02-07
Loading full text...

Full text loading...

/deliver/fulltext/acmi/5/6/acmi000457.html?itemId=/content/journal/acmi/10.1099/acmi.0.000457&mimeType=html&fmt=ahah

References

  1. Chen Y, Chen W, Zhou J, Sun C, Lei Y. Large pulmonary cavity in COVID-19 cured patient case report. Ann Palliat Med 2021; 10:5786–5791 [View Article]
    [Google Scholar]
  2. WHO Coronavirus (COVID-19) Dashboard. n.d https://covid19.who.int/ accessed 18 March 2022
  3. Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev 2008; 21:305–333 [View Article] [PubMed]
    [Google Scholar]
  4. Selvaraj V, Dapaah-Afriyie K. Lung cavitation due to COVID-19 pneumonia. BMJ Case Rep 2020; 13:1–2 [View Article] [PubMed]
    [Google Scholar]
  5. Yao XH, Li TY, He ZC et al. A pathological report of three COVID-19 cases by minimal invasive Autopsies. COVID-19 Inf 2020; 49:
    [Google Scholar]
  6. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15:102146 [View Article] [PubMed]
    [Google Scholar]
  7. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42:1417–1427 [View Article] [PubMed]
    [Google Scholar]
  8. Karapinar D. A review of a diagnostic tool: Galactomannan. J Immunological Sci 2018; 2:38–42 [View Article]
    [Google Scholar]
  9. Klont RR, Mennink-Kersten M, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004; 39:1467–1474 [View Article] [PubMed]
    [Google Scholar]
  10. Carpenter JL. Klebsiella pulmonary infections: occurrence at one medical center and review. Rev Infect Dis 1990; 12:672–682 [View Article] [PubMed]
    [Google Scholar]
  11. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 Suppl 4:S248–55 [View Article] [PubMed]
    [Google Scholar]
  12. Hammond JM, Potgieter PD, Hanslo D, Scott H, Roditi D. The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess. Chest 1995; 108:937–941 [View Article] [PubMed]
    [Google Scholar]
  13. Macfarlane J, Rose D. Radiographic features of staphylococcal pneumonia in adults and children. Thorax 1996; 51:539–540 [View Article]
    [Google Scholar]
  14. Yangco BG, Deresinski SC. Necrotizing or cavitating pneumonia due to Streptococcus pneumoniae: report of four cases and review of the literature. Med 1980; 59: [View Article]
    [Google Scholar]
  15. Robbins AW, Arora NS. Pulmonary cavitation caused by Haemophilus influenzae in adults. South Med J 1981; 74:225–227 [View Article] [PubMed]
    [Google Scholar]
  16. Chou DW, Wu SL, Lee CT. Intensive care unit-acquired complicated necrotizing pneumonia caused by Enterobacter cloacae: a case report. Intractable Rare Dis Res 2018; 7:283–286 [View Article] [PubMed]
    [Google Scholar]
  17. He D, Fu C, Ning M, Hu X, Li S et al. Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results. Front Cell Infect Microbiol 2022; 12:971933 [View Article] [PubMed]
    [Google Scholar]
  18. Boisvert AA, Cheng MP, Sheppard DC, Nguyen D. Microbial biofilms in pulmonary and critical care diseases. Ann Am Thorac Soc 2016; 13:1615–1623 [View Article] [PubMed]
    [Google Scholar]
  19. Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 2012; 25:450–470 [View Article] [PubMed]
    [Google Scholar]
  20. Fish DN, Choi MK, Jung R. Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. J Antimicrob Chemother 2002; 50:1045–1049 [View Article] [PubMed]
    [Google Scholar]
  21. Maeda A, Nakajima Y, Yanagisawa K, Sugimoto T, Harano K et al. Combination therapy with levofloxacin and cefepime to treat severe respiratory infection due to Aeromonas caviae after a near-drowning accident in river water. Acute Med Surg 2021; 8:e708 [View Article] [PubMed]
    [Google Scholar]
  22. Ciofu O, Rojo-Molinero E, Macià MD, Oliver A. Antibiotic treatment of biofilm infections. APMIS 2017; 125:304–319 [View Article] [PubMed]
    [Google Scholar]
  23. McAdams HP, Erasmus J, Winter JA. Radiologic of pulmonary tuberculosis. Radiol Clin North Am 1995; 33:655–678
    [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000457
Loading
/content/journal/acmi/10.1099/acmi.0.000457
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error